News

Upon the completion of the sale, which is expected in the second quarter of 2012, the facility’s employees will become the employees of Perryman. Accellent president and CEO

The R&D center will focus on the development of science-based nutrition products for maternal and child nutrition and diabetes care. Abbott Nutrition Global R&D and Scientific Affairs divisional

The deal is intended for the production of hyperimmune colostrum for Immuron’s products, including its Travelan treatment for travellers’ diarrhoea. Immuron chief executive officer Joe Baini said, "As

The company has received FDA regulatory clearance for the randomized, multicenter, open-label, active-controlled trial of F-627. Generon CEO Yu-Liang Huang said, "This is the first innovative biologic drug

After the review of the supplemental new drug application (sNDA), which was submitted in June 2011, the FDA has announced the decision. Sunovion executive vice president and chief

The US District Court for the District of Delaware has found both the patents in a suit brought against Mylan Pharmaceuticals are valid. Genentech, OSI, (a US affiliate

Nevirapine 200mg tablets are AB rated to Viramune, which is marketed by Boehringer Ingelheim. The non-nucleoside reverse transcriptase inhibitor (NNRTI) is indicated for the treatment of HIV-1 infection

The change in endpoint mean pain score relative to baseline is the primary efficacy endpoint in the A0081242 study. In the double-blind, randomized withdrawal efficacy and safety study,

The randomized, placebo-controlled study, which will enroll approximately 100 patients who have triglyceride levels of 500mg/dL or higher, is designed to evaluate ISIS-APOCIIIRx as a monotherapy and in